Botulinum toxin treatment of secondary headaches and cranial neuralgias: A review of evidence

Acta Neurologica Scandinavica

Volumn 124, Issue SUPPL. 191, 2011, Pages 50-55

  Linde, M ^a,b   Hagen, K ^a,b   Stovner, L J ^a,b  

^a NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^b TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

Author keywords

Botulinum toxin; Headache; Neuralgia; Review

Indexed keywords

BOTULINUM TOXIN;

ALOPECIA AREATA; ARTICLE; BLEPHAROSPASM; CRANIAL NEURALGIA; CRANIAL NEUROPATHY; FACE PAIN; HUMAN; NEURALGIA; SECONDARY HEADACHE; SYSTEMATIC REVIEW; TRIGEMINUS NEURALGIA; WHIPLASH INJURY; REVIEW; TREATMENT OUTCOME;

BOTULINUM TOXINS; CRANIAL NERVE DISEASES; HEADACHE DISORDERS, SECONDARY; HUMANS; NEURALGIA; TREATMENT OUTCOME;

EID: 79960058915     PISSN: 00016314     EISSN: 16000404     Source Type: Journal    
DOI: 10.1111/j.1600-0404.2011.01544.x     Document Type: Article

References (43)

1. Ashkenazi A, Silberstein S. Is botulinum toxin useful in treating headache? Yes. Curr Treat Options Neurol 2009;11:18-23.
2. Cady RK. OnabotulinumtoxinA (botulinum toxin type-A) in the prevention of migraine. Expert Opin Biol Ther. 2010;10:289-98.
3. Evers S. Review of botulinum toxin type A for the prophylactic treatment of chronic daily headache. Neuropsychiatr Dis Treat 2007;3:761-4.
4. Linde M, Hagen K, Salvesen Ø, Gravdahl G, Helde G, Stovner L. Onabotulinum toxin A treatment of cervicogenic headache: a randomized, double-blind, placebo-controlled cross-over study. Cephalalgia 2011; in press [Epub ahead of print]. DOI:
5. Headache Classification Subcommittee of the International Headache Society. The international classification of headache disorders. Cephalalgia 2004;24(Suppl 1):1-160.
6. CEBM Centre for Evidence-based Medicine. CEBM Web site. Levels of evidence and grades of recommendation. Accessed December 22, 2010.
7. Freund BJ, Schwartz M. Treatment of chronic cervical-associated headache with botulinum toxin A: a pilot study. Headache 2000;40:231-6.
8. Freund BJ, Schwartz M. Use of botulinum toxin in chronic whiplash-associated disorder. Clin J Pain 2002;18(6 Suppl):S163-8.
9. Aurora SK, Dodick DW, Turkel CC et al. OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial. Cephalalgia 2010;30:793-803.
10. Diener HC, Dodick DW, Aurora SK et al. OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial. Cephalalgia 2010;30:804-14.
11. 11.. Liu YC, Fuh JL, Chen RC, Lin KP, Wang SJ. Botulinum toxin type a in the prophylactic treatment of transformed migraine in Taiwanese patients: a review of 30 consecutive cases. J Chin Med Assoc 2007;70:535-40.
12. Hobson DE, Gladish DF. Botulinum toxin injection for cervicogenic headache. Headache 1997;37:253-5.
13. Smuts J, Barnard P. Botulinum toxin type A in the treatment of headache syndromes: a clinical report on 79 patients. Cephalalgia 2000;20:332.
14. Schnider P, Moraru E, Vigl M et al. Physical therapy and adjunctive botulinum toxin type A in the treatment of cervical headache: a double-blind, randomised, placebo-controlled study. J Headache Pain 2002;3:93-9.
15. Dowson AJ, Kilminster SG, Salt R. Clinical profile of botulinum toxin A in patients with chronic headaches and cervical dystonia: a prospective, open-label, longitudinal study conducted in a naturalistic clinical practice setting. Drugs R D 2008;9:147-58.
16. Ondo WG, Gollomp S, Galvez-Jimenez N. A pilot study of botulinum toxin A for headache in cervical dystonia. Headache 2005;45:1073-7.
17. Von Lindern JJ, Niederhagen B, Berge S, Appel T. Type A botulinum toxin in the treatment of chronic facial pain associated with masticatory hyperactivity. J Oral Maxillofac Surg 2003;61:774-8.
18. Guarda-Nardini L, Manfredini D, Salamone M, Salmaso L, Tonello S, Ferronato G. Efficacy of botulinum toxin in treating myofascial pain in bruxers: a controlled placebo pilot study. Cranio 2008;26:126-35.
19. Qerama E, Fuglsang-Frederiksen A, Jensen TS. The role of botulinum toxin in management of pain: an evidence-based review. Curr Opin Anaesthesiol 2010;23:602-10.
20. Borodic GE, Acquadro MA. The use of botulinum toxin for the treatment of chronic facial pain. J Pain 2002;3:21-7.
21. Freund BJ, Schwartz M. Relief of tension-type headache symptoms in subjects with temporomandibular disorders treated with botulinum toxin-A. Headache 2002;42:1033-7.
22. Song PC, Schwartz J, Blitzer A. The emerging role of botulinum toxin in the treatment of temporomandibular disorders. Oral Dis 2007;13:253-60.
23. Nixdorf DR, Heo G, Major PW. Randomized controlled trial of botulinum toxin A for chronic myogenous orofacial pain. Pain 2002;99:465-73.
24. Cutrer FM. Botulinum toxin a treatment in chronic daily headache. Headache 2005;45:270-1.
25. Cutrer FM, Pittelkow MR. Cephalalgic alopecia areata: a syndrome of neuralgiform head pain and hair loss responsive to botulinum A toxin injection. Cephalalgia 2006;26:747-51.
26. Johnstone SJ, Adler CH. Headache and facial pain responsive to botulinum toxin: an unusual presentation of blepharospasm. Headache 1998;38:366-8.
27. Cutrer FM, Sandroni P, Wendelschafer-Crabb G. Botulinum toxin treatment of cephalalgia alopecia increases substance P and calcitonin gene-related peptide-containing cutaneous nerves in scalp. Cephalalgia 2010;30:1000-6.
28. Micheli F, Scorticati MC, Raina G. Beneficial effects of botulinum toxin type a for patients with painful tic convulsif. Clin Neuropharmacol 2002;25:260-2.
29. Allam N, Brasil-Neto JP, Brown G, Tomaz C. Injections of botulinum toxin type a produce pain alleviation in intractable trigeminal neuralgia. Clin J Pain 2005;21:182-4.
30. Piovesan EJ, Teive HG, Kowacs PA, Della Coletta MV, Werneck LC, Silberstein SD. An open study of botulinum-A toxin treatment of trigeminal neuralgia. Neurology 2005;65:1306-8.
31. Turk U, Ilhan S, Alp R, Sur H. Botulinum toxin and intractable trigeminal neuralgia. Clin Neuropharmacol 2005;28:161-2.
32. Volcy M, Tepper SJ, Rapoport AM, Sheftell FD, Bigal ME. Botulinum toxin A for the treatment of greater occipital neuralgia and trigeminal neuralgia: a case report with pathophysiological considerations. Cephalalgia 2006;26:336-40.
33. Bosca-Blasco ME, Burguera-Hernandez JA, Roig-Morata S, Martinez-Torres I. Painful tic convulsif and Botulinum toxin. Rev Neurol 2006;42:729-32.
34. Uluduz D, Karaali-Savrun F, Gunduz A, Kiziltan ME. An unusual case of vascular loop syndrome. J Headache Pain 2007;8:242-4.
35. Zuniga C, Diaz S, Piedimonte F, Micheli F. Beneficial effects of botulinum toxin type A in trigeminal neuralgia. Arq Neuropsiquiatr 2008;66:500-3.
36. Bohluli B, Motamedi MH, Bagheri SC et al. Use of botulinum toxin A for drug-refractory trigeminal neuralgia: preliminary report. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2011;111:47-50.
37. Ngeow WC, Nair R. Injection of botulinum toxin type A (BOTOX) into trigger zone of trigeminal neuralgia as a means to control pain. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2010;109:e47-50.
38. Yoon SH, Merrill RL, Choi JH, Kim ST. Use of botulinum toxin type A injection for neuropathic pain after trigeminal nerve injury. Pain Med 2010;11:630-2.
39. Dusitanond P, Young W. Botulinum toxin type A's efficacy in nummular headache. Headache 2008;48:1379.
40. Mathew NT, Kailasam J, Meadors L. Botulinum toxin type A for the treatment of nummular headache: four case studies. Headache 2008;48:442-7.
41. Ruscheweyh R, Buchheister A, Gregor N, Jung A, Evers S. Nummular headache: six new cases and lancinating pain attacks as possible manifestation. Cephalalgia 2010;30:249-53.
42. Kapural L, Stillman M, Kapural M, McIntyre P, Guirgius M, Mekhail N. Botulinum toxin occipital nerve block for the treatment of severe occipital neuralgia: a case series. Pain Pract 2007;7:337-40.
43. Taylor M, Silva S, Cottrell C. Botulinum toxin type-A (BOTOX) in the treatment of occipital neuralgia: a pilot study. Headache 2008;48:1476-81.